Navigation Links
Hotspur Technologies Commences US Launch at Veith/AIM Conference in New York City
Date:11/16/2011

NEW YORK, Nov. 16, 2011 /PRNewswire/ -- Hotspur Technologies today announced the launch of the company's GPSCath™ Balloon Dilatation Catheter in the United States and select international markets.  The company made the announcement today.  

Hotspur's innovative GPSCath™ Balloon Dilatation Catheter integrates a proprietary valve into a balloon catheter, allowing physicians to inject contrast during a procedure without the need for removal of the balloon catheter or adjustment of guidewire position.  Combining these multiple functions into one device can potentially reduce the time and expense required to complete peripheral angioplasty procedures, allowing physicians to work more efficiently.

To support this initial launch, Hotspur has entered into exclusive distribution agreements with SurgPro, LLC, and TD Medical, leading medical device distributors in the interventional radiology space for the southeastern United States and the Netherlands, respectively.  While these regions are the initial focus of Hotspur's launch, the company will continue to expand its distribution network throughout the United States and other select international markets in 2012.

"My use of the GPSCath™ has been a highly positive experience, and I look forward to using more of these devices in the future as well as seeing what other innovations Hotspur will bring to the market," said Dr. Tom DiBartholomeo, an interventional radiologist and early adopter of the product.

During the company's recently completed limited market launch, over 150 GPSCath™ balloon catheters were successfully used in more than 100 dialysis access procedures.  This initial product experience validated the performance of both the angioplasty and injection functions of the GPSCath™, while also reinforcing the benefit of combining the multiple functions into one unique catheter.  

"I am very excited about the launch of GPSCath™.  We have been very impressed with the device performance, and we feel that the GPSCath™ will make a significant impact in providing better care for patients and reducing procedure times for physicians," said Gwen Watanabe, President & CEO of Hotspur Technologies. "In the near future, I am also looking forward to launching a number of new novel products in the US market, which will underscore the strength of the company's pipeline and the depth of our R&D."

About Hotspur Technologies

Founded in 2008 and located in Mountain View, California, Hotspur Technologies (www.hotspur-inc.com) is a leading developer of catheter-based technologies aimed at restoring blood flow for patients with obstructed vessels.  The company's products are based on a unique technology that opens blood vessels more efficiently and less invasively. The firm's VisioValve™ technology serves as a launching point to improve patient outcome and physician efficiency. Hotspur is privately held.  Its investors include ONSET Ventures, Finistere Ventures, BioStar Ventures, Saratoga Ventures, Millennium Life Sciences Ventures, Incept, and Versant Ventures.

CONTACT: Will Martin, (770) 639-2777, will@hotspur-inc.com


'/>"/>
SOURCE Hotspur Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hotspur Technologys Novel 3-in-1 Angioplasty Balloon Successfully Achieves First Commercial Deployment
2. Hotspur Technologies Continues to Bring Innovations to Peripheral Vascular Market
3. First Hotspur Peripheral Angioplasty Case Completed
4. Hotspurs Keeper Embolectomy Catheter Deployed for First Time
5. Hotspur Technologies’ IQCath Catheter Receives CE Mark
6. Hotspur Technologies Appoints Fred Khosravi Chairman of the Board
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
9. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
10. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
11. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... , Aug. 15, 2017  AOTI Inc. announced today that its ... Inc., has recently opened a New York City Office in ... of its unique Topical Wound Oxygen (TWO 2 ) homecare therapy. ... Accreditation Commission for Health Care (ACHC) under the company,s DMEPOS accreditation ... ...
(Date:8/11/2017)... -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... today announced that it will release its second quarter ... conference call at 9:00am ET. The Company will discuss ... its strategy and outlook for the remainder of 2017. The ... , Chief Executive Officer, and Zvi Ben-David , ...
(Date:8/8/2017)... TEL AVIV, Israel, Aug. 8, 2017  BioLineRx Ltd. ... and immunology, today reports its financial results for the ... and achievements during the second quarter 2017 and to ... on multiple clinical development programs for the Company,s lead ... Phase 3 pivotal study with BL-8040 as novel stem ...
Breaking Medicine Technology:
(Date:8/23/2017)... ... 2017 , ... The non-profit Seafood Nutrition Partnership (SNP) ... the Science Symposium in partnership with the Global Organization for EPA and DHA ... a forum for global leaders in human nutrition to outline the latest consensus ...
(Date:8/22/2017)... ... August 22, 2017 , ... Western North ... at a popular international aesthetics conference for medical professionals about the positive impact ... health and his growing practice. , Dr. George K. Ibrahim shared ...
(Date:8/22/2017)... ... 22, 2017 , ... Nurses at Apple Rehab Watch Hill , a ... training and certification in Closed Pulse Irrigation™ (CPI) for wound care. This ... the Centers for Medicare and Medicaid Services, to have a CPI machine that will ...
(Date:8/22/2017)... , ... August 22, 2017 , ... ... story of child abuse and neglect, and the struggles faced while hoping for ... the creation of published author, Judy Von Bernewitz, who spent 13 years working ...
(Date:8/22/2017)... ... August 22, 2017 , ... TopConsumerReviews.com recently gave a best-in-class 5-star rating ... , As the stress of modern life continually makes more demands on time and ... artificial stimulants can trap people in vicious high/low cycles and can also cause long ...
Breaking Medicine News(10 mins):